Sözen Hakan, Kozan Ramazan, Hüseyn Behruz, Fidan Kibriya, Dalgıç Aydın
>From Transplantation Center, Gazi University Medical School, Ankara, and the Department of Surgery, Gazi University Medical School, Ankara, Türkiye.
Exp Clin Transplant. 2025 Jul;23(7):460-465. doi: 10.6002/ect.2025.0066.
Renal transplant is the most appropriate treatment for adult and pediatric patients with end-stage renal failure.
Fifty-one pediatric kidney transplants were performed in 49 pediatric recipients from a total of 263 kidney recipients at the Gazi University Transplantation Center (Türkiye) between January 2006 and January 2021. We gathered and analyzed data retrospectively from hospital medical records of pediatric transplant recipients.
Kidney grafts were obtained from 18 deceased (35%) and 33 living donors (65%). Among 51 pediatric renal transplants, 10 (19.6%) had complications, with 6 early and 4 late complications. Among 6 early complications posttransplant, 5 were surgical complications (9.8%) and 1 (1.9%) was urologic (1.9%), but no vascular complications were seen. Among 5 surgical complications, 3 (5.8%) were lymphocele and 2 were (3.9%) bleeding complications. Among 4 patients with late complications, 2 had renal artery stenosis and 2 had ureter stenosis. Two patients required re-transplantation because of graft loss from BK virus nephropathy and chronic allograft nephropathy. Among 51 pediatric kidney transplants, 15 recipients (29.4%) presented with 27 cases of infection. Twenty-one acute rejection episodes were seen in 14 of 51 pediatric transplant procedures (27.4%), and 4 humoral rejections occurred in 3 of 51 pediatric transplant procedures (5.8%). In addition, 27 renal transplant patients (52.9%) had normal graft functions at median follow-up of 95 months (98.7 ± 57.7; range, 58-233 mo). Twenty-eight of 51 patients (54.9%) lost kidney grafts over a 15-year follow-up. No graft loss or patient deaths occurred because of surgical complications.
In analysis of 15 years of experience in pediatric renal transplants, our results were within results of other series. Pediatric renal transplant is a safe procedure in our department, based on patient and graft survivals, with no graft loss from surgical complications.
肾移植是终末期肾衰竭成人及儿童患者最适宜的治疗方法。
2006年1月至2021年1月期间,在加齐大学移植中心(土耳其)的263例肾移植受者中,49例儿童受者接受了51例儿童肾移植手术。我们从儿童移植受者的医院病历中回顾性收集并分析了数据。
肾移植供肾来自18例死者(35%)和33例活体供者(65%)。在51例儿童肾移植中,10例(19.6%)出现并发症,其中6例为早期并发症,4例为晚期并发症。在移植后的6例早期并发症中,5例为手术并发症(9.8%),1例为泌尿系统并发症(1.9%),未见血管并发症。在5例手术并发症中,3例(5.8%)为淋巴囊肿,2例(3.9%)为出血并发症。在4例晚期并发症患者中,2例有肾动脉狭窄,2例有输尿管狭窄。2例患者因BK病毒肾病和慢性移植肾肾病导致移植肾丢失而需要再次移植。在51例儿童肾移植中,15例受者(29.4%)出现27例感染。51例儿童移植手术中的14例(27.4%)出现21次急性排斥反应,51例儿童移植手术中的3例(5.8%)出现4次体液排斥反应。此外,27例肾移植患者(52.9%)在中位随访95个月(98.7±57.7;范围58 - 233个月)时移植肾功能正常。51例患者中有28例(54.9%)在15年的随访中移植肾丢失。未因手术并发症导致移植肾丢失或患者死亡。
通过对15年儿童肾移植经验的分析,我们的结果与其他系列研究结果相符。基于患者和移植肾的存活率,儿童肾移植在我们科室是一种安全的手术,未因手术并发症导致移植肾丢失。